Search Results - "Doehring, Alexandra"

Effect Sizes in Experimental Pain Produced by Gender, Genetic Variants and Sensitization Procedures.

Authors: Doehring, Alexandra Küsener, Nele Flühr, Karin et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 3, p1-9. 9p.

Functional genomics of pain in analgesic drug development and therapy.

Authors: Lötsch, Jörn Doehring, Alexandra Mogil, Jeffrey S. et al.

Source: Pharmacology & Therapeutics. Jul2013, Vol. 139 Issue 1, p60-70. 11p.

Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain

Authors: Doehring, Alexandra Oertel, Bruno Georg Sittl, Reinhard et al.

Source: PAIN. Jan2013, Vol. 154 Issue 1, p15-23. 9p.

Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy.

Authors: Doehring, Alexandra Hofmann, Wolf Peter Schlecker, Christina et al.

Source: Pharmacogenetics. May2011, Vol. 21 Issue 5, p289-296. 8p.

Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.

Authors: Doehring, Alexandra Hentig, Nils Von Graff, Jochen et al.

Source: Pharmacogenetics. Jun2009, Vol. 19 Issue 6, p407-414. 8p.

Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk

Authors: Doehring, Alexandra Antoniades, Charalambos Channon, Keith M. et al.

Source: Mutation Research/Reviews in Mutation Research. Sep2008, Vol. 659 Issue 3, p195-201. 7p.

Rapid screening for potentially relevant polymorphisms in the human fatty acid amide hydrolase gene using Pyrosequencing™

Authors: Doehring, Alexandra Geisslinger, Gerd Lötsch, Jörn

Source: Prostaglandins & Other Lipid Mediators. Nov2007, Vol. 84 Issue 3/4, p128-137. 10p.

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection

Authors: Lange, Christian M. Moradpour, Darius Doehring, Alexandra et al.

Source: Journal of Hepatology. Aug2011, Vol. 55 Issue 2, p322-327. 6p.

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

Authors: Sarrazin, Christoph Susser, Simone Doehring, Alexandra et al.

Source: Journal of Hepatology. Mar2011, Vol. 54 Issue 3, p415-421. 7p.

A GTP cyclohydrolase 1 genetic variant delays cancer pain

Authors: Lötsch, Jörn Klepstad, Pål Doehring, Alexandra et al.

Source: PAIN. Jan2010, Vol. 148 Issue 1, p103-106. 4p.

Disagreement between two common biomarkers of global DNA methylation.

Authors: Knothe, Claudia Hiromi Shiratori Resch, Eduard et al.

Source: Clinical Epigenetics. 5/23/2016, Vol. 8, p1-17. 17p.

Consequences of a Human TRPA1 Genetic Variant on the Perception of Nociceptive and Olfactory Stimuli.

Authors: Schütz, Michael Oertel, Bruno G. Heimann, Dirk et al.

Source: PLoS ONE. Apr2014, Vol. 9 Issue 4, p1-8. 8p.

Linkage between Increased Nociception and Olfaction via a SCN9A Haplotype.

Authors: Heimann, Dirk Lötsch, Jörn Hummel, Thomas et al.

Source: PLoS ONE. Jul2013, Vol. 8 Issue 7, p1-6. 6p.

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers.

Authors: Vermehren, Johannes Lötsch, Jörn Susser, Simone et al.

Source: PLoS ONE. Mar2012, Vol. 7 Issue 3, p1-5. 5p.

Functional genomics suggest neurogenesis in the adult human olfactory bulb.

Authors: Lötsch, Jörn Schaeffeler, Elke Mittelbronn, Michel et al.

Source: Brain Structure & Function. Nov2014, Vol. 219 Issue 6, p1991-2000. 10p.

Common non-epigenetic drugs as epigenetic modulators.

Authors: Lötsch, Jörn Schneider, Gisbert Reker, Daniel et al.

Source: Trends in Molecular Medicine. Dec2013, Vol. 19 Issue 12, p742-753. 12p.

Necessity and Risks of Arterial Blood Sampling in Healthy Volunteer Studies.

Authors: Oertel, Bruno Georg Vermehren, Johannes Zimmermann, Michael et al.

Source: Clinical Pharmacokinetics. 2012, Vol. 51 Issue 10, p629-638. 10p.

A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size.

Authors: Lötsch, Jörn Prüss, Harald Veh, Rüdiger W. et al.

Source: Pharmacogenetics. May2010, Vol. 20 Issue 5, p291-297. 7p.

Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?

Authors: Lötsch, Jörn Rohrbacher, Maren Schmidt, Helmut et al.

Source: PAIN. Jul2009, Vol. 144 Issue 1/2, p119-124. 6p.

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.

Authors: Lötsch, Jörn Von Hentig, Nils Freynhagen, Rainer et al.

Source: Pharmacogenetics. Jun2009, Vol. 19 Issue 6, p429-436. 8p.